RIVELSA Trademark

Trademark Overview

On Tuesday, September 15, 2015, a trademark application was filed for RIVELSA with the United States Patent and Trademark Office. The USPTO has given the RIVELSA trademark a serial number of 86756912. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, February 5, 2024. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The RIVELSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, oral contraceptives
rivelsa

General Information

Serial Number86756912
Word MarkRIVELSA
Filing DateTuesday, September 15, 2015
Status710 - CANCELLED - SECTION 8
Status DateMonday, February 5, 2024
Registration Number5219225
Registration DateTuesday, June 6, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, oral contraceptives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, February 5, 2024
Primary Code005
First Use Anywhere DateMonday, April 3, 2017
First Use In Commerce DateMonday, April 3, 2017

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Tuesday, February 6, 2024NOTICE OF CANCELLATION SEC. 8 EMAILED
Monday, February 5, 2024CANCELLED SEC. 8 (6-YR)
Saturday, July 29, 2023POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Saturday, July 29, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 2, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, June 6, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 6, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, May 4, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 3, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 21, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 4, 2017USE AMENDMENT FILED
Friday, April 14, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 4, 2017TEAS STATEMENT OF USE RECEIVED
Saturday, April 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 30, 2017SOU EXTENSION 2 GRANTED
Thursday, March 30, 2017SOU EXTENSION 2 FILED
Thursday, March 30, 2017SOU TEAS EXTENSION RECEIVED
Friday, September 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2016SOU EXTENSION 1 GRANTED
Wednesday, September 28, 2016SOU EXTENSION 1 FILED
Wednesday, September 28, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, April 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 31, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 30, 2015ASSIGNED TO EXAMINER
Friday, September 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 18, 2015NEW APPLICATION ENTERED

Related Keywords

rivelsa contraceptives oral namely preparations pharmaceutical